Get started
Author

Doris A. Phelps

Nucleoside transport in normal and neoplastic cells
1993 · Judith A. Belt, Neyssa M. Marina, et al. · Advances in Enzyme Regulation · 163
High-level expression, purification, and characterization of recombinant human tumor necrosis factor synthesized in the methylotrophic yeast Pichia pastoris
1989 · K. Sreekrishna, Lynn Nelles, et al. · Biochemistry · 154
Development of a Tumor-Selective Approach to Treat Metastatic Cancer
2006 · Karen S. Aboody, Rebecca A. Bush, et al. · PLoS ONE · 125
PDF
Molecular Characterization of the Pediatric Preclinical Testing Panel
2008 · Geoffrey Neale, Xiaoping Su, et al. · Clinical Cancer Research · 118
Initial testing (stage 1) of AZD6244 (ARRY‐142886) by the pediatric preclinical testing program
2010 · E. Anders Kolb, Richard Gorlick, et al. · Pediatric Blood & Cancer · 112
Regulation of FANCD2 by the mTOR Pathway Contributes to the Resistance of Cancer Cells to DNA Double-Strand Breaks
2013 · Changxian Shen, Duane Oswald, et al. · Cancer Research · 92
High level expression of heterologous proteins in methylotrophic yeast Pichia pastoris
1988 · K. Sreekrishna, Rica H. B. Potenz, et al. · Journal of Basic Microbiology · 92
The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma
2016 · Hemant K. Bid, Doris A. Phelps, et al. · Molecular Cancer Therapeutics · 88
IL-6 and CXCL8 mediate osteosarcoma-lung interactions critical to metastasis
2018 · Amy C. Gross, Hakan Cam, et al. · JCI Insight · 82
PDF
Potent Inhibition of Angiogenesis by the IGF-1 Receptor-Targeting Antibody SCH717454 Is Reversed by IGF-2
2011 · Hemant K. Bid, Jun Zhan, et al. · Molecular Cancer Therapeutics · 66
SK‐NEP‐1 and Rh1 are Ewing family tumor lines
2006 · Malcolm A. Smith, Christopher L. Morton, et al. · Pediatric Blood & Cancer · 65
Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma
2013 · Hemant K. Bid, Aaron Kibler, et al. · Clinical Cancer Research · 59
Initial testing (stage 1) of the cyclin dependent kinase inhibitor SCH 727965 (dinaciclib) by the pediatric preclinical testing program
2012 · Richard Gorlick, E. Anders Kolb, et al. · Pediatric Blood & Cancer · 40
PDF
Surfaceome Profiling of Rhabdomyosarcoma Reveals B7-H3 as a Mediator of Immune Evasion
2021 · Roxane R. Lavoie, Patricio C. Gargollo, et al. · Cancers · 39
PDF
Initial testing (stage 1) of the mTOR kinase inhibitor AZD8055 by the pediatric preclinical testing program
2011 · Peter J. Houghton, Richard Gorlick, et al. · Pediatric Blood & Cancer · 39
Stage 1 testing and pharmacodynamic evaluation of the HSP90 inhibitor alvespimycin (17‐DMAG, KOS‐1022) by the pediatric preclinical testing program
2008 · Malcolm A. Smith, Christopher L. Morton, et al. · Pediatric Blood & Cancer · 34
Initial testing of the hypoxia‐activated prodrug PR‐104 by the pediatric preclinical testing program
2010 · Peter J. Houghton, Richard Lock, et al. · Pediatric Blood & Cancer · 33
Initial testing (stage 1) of lapatinib by the pediatric preclinical testing program
2009 · Richard Gorlick, E. Anders Kolb, et al. · Pediatric Blood & Cancer · 31
ICAM-2 Expression Mediates a Membrane-Actin Link, Confers a Nonmetastatic Phenotype and Reflects Favorable Tumor Stage or Histology in Neuroblastoma
2008 · Karina Jin Yoon, Doris A. Phelps, et al. · PLoS ONE · 28
PDF
Inhibition of MDM2 by RG7388 confers hypersensitivity to X‐radiation in xenograft models of childhood sarcoma
2015 · Doris Phelps, Kathryn Bondra, et al. · Pediatric Blood & Cancer · 27
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting
2023 · Silvia Pomella, Matteo Cassandri, et al. · Nature Communications · 25
PDF
Single-cell RNA profiling identifies diverse cellular responses to EWSR1/FLI1 downregulation in Ewing sarcoma cells
2022 · Roxane Khoogar, Fuyang Li, et al. · Cellular Oncology · 24
Evaluation of entinostat alone and in combination with standard‐of‐care cytotoxic agents against rhabdomyosarcoma xenograft models
2019 · Raushan T. Kurmasheva, Abhik Bandyopadhyay, et al. · Pediatric Blood & Cancer · 24
Evaluation of Eribulin Combined with Irinotecan for Treatment of Pediatric Cancer Xenografts
2020 · Andrew J. Robles, Raushan T. Kurmasheva, et al. · Clinical Cancer Research · 17
Evaluation of VTP‐50469, a menin‐MLL1 inhibitor, against Ewing sarcoma xenograft models by the pediatric preclinical testing consortium
2020 · Raushan T. Kurmasheva, Abhik Bandyopadhyay, et al. · Pediatric Blood & Cancer · 16
PDF
Works count: 97
Citation count: 1,673
H-index: 23
I10-index: 29
Year
Topic
Type